UrgoTouch®
Because every patient deserves a confident result
Backed by clinical studies, our laser technology has been proven to reduce surgical scars by up to 53%*, helping your patients heal with confidence. With precision treatment and optimized healing, you can elevate both results and patient satisfaction.
How does UrgoTouch® work?
UrgoTouch® is a laser technology designed to optimize healing. Clinical studies show it can decrease surgical scar volume by up to 53%*, and it is suitable for all skin phototypes (I to VI). With just a single session performed in the operating room at the end of any body surgery**, UrgoTouch® makes advanced scar management simple and effective.
Why choose UrgoTouch® for your patients?
- Decreases surgical scars volume by up to 53%. *
- UrgoTouch® laser can be used on all skin prototypes (I to V).
- Requires 1 single session in the operating room at the end of any body surgery. **
- Engineered for convenience, UrgoTouch® delivers advanced performance in a compact device.
SLASH
Published clinical study
The SLASH double-blinded clinical study conducted on 40 breast reduction patients showed that scars treated with UrgoTouch® achieved up to 53% volume reduction* compared to controls.
Independent assessments with 3D photo software, clinical investigators, and patient feedback confirmed the results, with twice as many patients preferring their treated scar.
Who are we?
The UrgoTouch® laser is owned by the Urgo Group, a french company with a 100% family-owned shareholder base enabling it to undertake bold projects and to anchor long-term investments.
200
R&D Employees
55
Studies since 1997
300M€
R&D Investments
(2020 – 2030)
80M€
Invested in plants
(2020 – 2023)
What our clients say about the treatment
Frequently asked questions
Over 300 surgeons in France and Spain are using UrgoTouch® to treat their patients on a regular basis. These are some of the most common questions we get asked. For all questions please visit our FAQ page.
What is the difference between UrgoTouch® and other lasers dedicated to scar optimization?
UrgoTouch® is the only laser dedicated to scar optimization that is used in the operations room directly after suturing (allowing it to act from the very beginning of the initial healing phase) and requires only one session.
Can the laser be used on all skin types?
Yes, the UrgoTouch® laser can be used on all phototypes (I to V).
How many patients have benefited from the laser?
Today, more than 40,000 patients have already benefited from the UrgoTouch® laser.
At what point during the operation is the laser used?
The UrgoTouch® laser requires a single application in the operating room when the patient is under anesthesia. It is performed at the end of the surgical procedure, onze the surgeon has completed the suturing.
How many doctors are using the laser?
Over 300 doctors trust the UrgoTouch® device for scar optimization.
Do you have any other questions?
*Contraindication for cancer and not recommended for the face
**A 1 Year Follow-up of Post-operative Scars After the Use of a 1210nm Laser Assisted Skin Healing (LASH) Technology: A Randomized Controlled Trial. D.Casanova, ed. Aesthetic Plastic Surgery Journal. Feb 2017 – Reduction of 53% observed in a patient with dark phototype